Computed Tomography Evaluation of Urinary Stones Densities Compared to in Vitro Analysis of Its Chemical Composition
1 other identifier
observational
100
0 countries
N/A
Brief Summary
The ability to predict stone composition, which influences patient treatment, depends on the accurate measurement of CT attenuation of stones. We will study the effects of stone composition, stone size, and scan collimation width on the measurement of attenuation in vitro.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2019
CompletedFirst Posted
Study publicly available on registry
October 1, 2019
CompletedStudy Start
First participant enrolled
March 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedFebruary 5, 2020
February 1, 2020
2.4 years
September 28, 2019
February 1, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
comparison of CT densities of urinary stones with its chemical composition
determination whether the composition of urinary calculi could be predicted by their CT characteristics in an attempt to find out the best technique for distinguishing the various stones compositions .
Baseline
Eligibility Criteria
Patients with suspected or known urinary stone disease and were included in the study who attend to out patient clinic of Urology department of Assiut university hospital or admitted in the ward.
You may qualify if:
- Any Age will be included .
- Patient with suspected or known urinary stone disease.
- Eligible for doing NCCT.
- Giving written consent to participate
You may not qualify if:
- Patient with classical NCCT contraindication like morbid obesity and pregnancy .
- Patients with urinary stones will be treated by ESWL
- Refusal participation .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor
Study Record Dates
First Submitted
September 28, 2019
First Posted
October 1, 2019
Study Start
March 30, 2020
Primary Completion
September 1, 2022
Study Completion
October 30, 2022
Last Updated
February 5, 2020
Record last verified: 2020-02